Do analysts prefer CDLX or CMCM?

Cardlytics currently has a consensus target price of $1.00, suggesting a potential upside of 67.11%. Given Cardlytics' stronger consensus rating and higher possible upside, equities analysts plainly believe Cardlytics is more favorable than Cheetah Mobile. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cardlytics 2 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.33 Cheetah Mobile 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend PODC or CDLX?

Cardlytics has a consensus price target of $1.00, suggesting a potential upside of 67.11%. Given Cardlytics' higher possible upside, analysts clearly believe Cardlytics is more favorable than PodcastOne. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PodcastOne 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Cardlytics 2 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.33

Is PODC or CDLX more profitable?

PodcastOne has a net margin of -6.22% compared to Cardlytics' net margin of -46.03%. PodcastOne's return on equity of -24.78% beat Cardlytics' return on equity. Company Net Margins Return on Equity Return on Assets PodcastOne -6.22% -24.78% -16.46% Cardlytics -46.03% -956.56% -34.57%

Is CDLX or ARBE more profitable?

Cardlytics has a net margin of -46.03% compared to Arbe Robotics' net margin of -2,817.97%. Arbe Robotics' return on equity of -83.44% beat Cardlytics' return on equity. Company Net Margins Return on Equity Return on Assets Cardlytics -46.03% -956.56% -34.57% Arbe Robotics -2,817.97% -83.44% -54.47%

Do analysts rate CDLX or RAAS?

Cardlytics presently has a consensus price target of $1.00, indicating a potential upside of 67.11%. Given Cardlytics' stronger consensus rating and higher probable upside, analysts clearly believe Cardlytics is more favorable than Cloopen Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cardlytics 2 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.33 Cloopen Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation and earnings, CDLX or RAAS?

Cloopen Group has lower revenue, but higher earnings than Cardlytics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cardlytics $233.27M 0.15 -$103.49M -$1.77 N/A Cloopen Group $76.61M 1.56 -$34.23M N/A N/A

Cardlytics (CDLX) Competitors

$0.60 -0.01 (-1.92%)

Closing price 04:00 PM Eastern

Extended Trading

$0.60 +0.00 (+0.27%)

As of 07:49 PM Eastern

Compare

CDLX vs. CMCM, PODC, ARBE, SANG, and RAAS

Should you buy Cardlytics stock or one of its competitors? MarketBeat compares Cardlytics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cardlytics include Cheetah Mobile (CMCM), PodcastOne (PODC), Arbe Robotics (ARBE), Sangoma Technologies (SANG), and Cloopen Group (RAAS). These companies are all part of the "computer software" industry.

How does Cardlytics compare to Cheetah Mobile?

Cardlytics (NASDAQ:CDLX) and Cheetah Mobile (NYSE:CMCM) are both small-cap computer software companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment.

Cheetah Mobile has a net margin of -22.66% compared to Cardlytics' net margin of -46.03%. Cheetah Mobile's return on equity of -4.37% beat Cardlytics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardlytics	-46.03%	-956.56%	-34.57%
Cheetah Mobile	-22.66%	-4.37%	-1.70%

Cardlytics has a beta of 0.58, suggesting that its stock price is 42% less volatile than the broader market. Comparatively, Cheetah Mobile has a beta of 1.77, suggesting that its stock price is 77% more volatile than the broader market.

68.1% of Cardlytics shares are held by institutional investors. Comparatively, 0.4% of Cheetah Mobile shares are held by institutional investors. 5.9% of Cardlytics shares are held by insiders. Comparatively, 17.1% of Cheetah Mobile shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Cardlytics currently has a consensus target price of $1.00, suggesting a potential upside of 67.11%. Given Cardlytics' stronger consensus rating and higher possible upside, equities analysts plainly believe Cardlytics is more favorable than Cheetah Mobile.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardlytics	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33
Cheetah Mobile	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Cheetah Mobile has lower revenue, but higher earnings than Cardlytics. Cheetah Mobile is trading at a lower price-to-earnings ratio than Cardlytics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardlytics	$233.27M	0.15	-$103.49M	-$1.77	N/A
Cheetah Mobile	$164.51M	0.75	-$36.85M	-$1.25	N/A

In the previous week, Cardlytics and Cardlytics both had 1 articles in the media. Cheetah Mobile's average media sentiment score of 0.00 beat Cardlytics' score of -2.00 indicating that Cheetah Mobile is being referred to more favorably in the news media.

Company	Overall Sentiment
Cardlytics	Very Negative
Cheetah Mobile	Neutral

Summary

Cheetah Mobile beats Cardlytics on 9 of the 14 factors compared between the two stocks.

How does Cardlytics compare to PodcastOne?

PodcastOne (NASDAQ:PODC) and Cardlytics (NASDAQ:CDLX) are both small-cap computer software companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings and risk.

PodcastOne has a beta of 1.98, indicating that its share price is 98% more volatile than the broader market. Comparatively, Cardlytics has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market.

2.9% of PodcastOne shares are owned by institutional investors. Comparatively, 68.1% of Cardlytics shares are owned by institutional investors. 79.4% of PodcastOne shares are owned by insiders. Comparatively, 5.9% of Cardlytics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

PodcastOne has higher earnings, but lower revenue than Cardlytics. PodcastOne is trading at a lower price-to-earnings ratio than Cardlytics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PodcastOne	$52.12M	2.23	-$6.46M	-$0.15	N/A
Cardlytics	$233.27M	0.15	-$103.49M	-$1.77	N/A

In the previous week, Cardlytics had 1 more articles in the media than PodcastOne. MarketBeat recorded 1 mentions for Cardlytics and 0 mentions for PodcastOne. PodcastOne's average media sentiment score of 0.00 beat Cardlytics' score of -2.00 indicating that PodcastOne is being referred to more favorably in the media.

Company	Overall Sentiment
PodcastOne	Neutral
Cardlytics	Very Negative

Cardlytics has a consensus price target of $1.00, suggesting a potential upside of 67.11%. Given Cardlytics' higher possible upside, analysts clearly believe Cardlytics is more favorable than PodcastOne.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PodcastOne	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Cardlytics	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33

PodcastOne has a net margin of -6.22% compared to Cardlytics' net margin of -46.03%. PodcastOne's return on equity of -24.78% beat Cardlytics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PodcastOne	-6.22%	-24.78%	-16.46%
Cardlytics	-46.03%	-956.56%	-34.57%

Summary

PodcastOne beats Cardlytics on 10 of the 15 factors compared between the two stocks.

How does Cardlytics compare to Arbe Robotics?

Cardlytics (NASDAQ:CDLX) and Arbe Robotics (NASDAQ:ARBE) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, analyst recommendations, profitability and dividends.

Cardlytics has a net margin of -46.03% compared to Arbe Robotics' net margin of -2,817.97%. Arbe Robotics' return on equity of -83.44% beat Cardlytics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardlytics	-46.03%	-956.56%	-34.57%
Arbe Robotics	-2,817.97%	-83.44%	-54.47%

Arbe Robotics has lower revenue, but higher earnings than Cardlytics. Arbe Robotics is trading at a lower price-to-earnings ratio than Cardlytics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardlytics	$233.27M	0.15	-$103.49M	-$1.77	N/A
Arbe Robotics	$1.03M	108.36	-$46.42M	-$0.36	N/A

Cardlytics has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market. Comparatively, Arbe Robotics has a beta of 1.06, indicating that its share price is 6% more volatile than the broader market.

68.1% of Cardlytics shares are held by institutional investors. Comparatively, 33.4% of Arbe Robotics shares are held by institutional investors. 5.9% of Cardlytics shares are held by insiders. Comparatively, 53.5% of Arbe Robotics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Cardlytics presently has a consensus target price of $1.00, suggesting a potential upside of 67.11%. Arbe Robotics has a consensus target price of $2.33, suggesting a potential upside of 156.41%. Given Arbe Robotics' stronger consensus rating and higher probable upside, analysts clearly believe Arbe Robotics is more favorable than Cardlytics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardlytics	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33
Arbe Robotics	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Arbe Robotics had 4 more articles in the media than Cardlytics. MarketBeat recorded 5 mentions for Arbe Robotics and 1 mentions for Cardlytics. Arbe Robotics' average media sentiment score of 0.45 beat Cardlytics' score of -2.00 indicating that Arbe Robotics is being referred to more favorably in the news media.

Company	Overall Sentiment
Cardlytics	Very Negative
Arbe Robotics	Neutral

Summary

Arbe Robotics beats Cardlytics on 11 of the 16 factors compared between the two stocks.

How does Cardlytics compare to Sangoma Technologies?

Sangoma Technologies (NASDAQ:SANG) and Cardlytics (NASDAQ:CDLX) are both small-cap computer software companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, analyst recommendations, profitability and valuation.

Sangoma Technologies has a beta of 1.29, suggesting that its share price is 29% more volatile than the broader market. Comparatively, Cardlytics has a beta of 0.58, suggesting that its share price is 42% less volatile than the broader market.

Sangoma Technologies presently has a consensus target price of $4.00, indicating a potential upside of 14.29%. Cardlytics has a consensus target price of $1.00, indicating a potential upside of 67.11%. Given Cardlytics' higher probable upside, analysts plainly believe Cardlytics is more favorable than Sangoma Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sangoma Technologies	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cardlytics	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33

39.7% of Sangoma Technologies shares are held by institutional investors. Comparatively, 68.1% of Cardlytics shares are held by institutional investors. 14.0% of Sangoma Technologies shares are held by company insiders. Comparatively, 5.9% of Cardlytics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Sangoma Technologies had 2 more articles in the media than Cardlytics. MarketBeat recorded 3 mentions for Sangoma Technologies and 1 mentions for Cardlytics. Sangoma Technologies' average media sentiment score of 0.52 beat Cardlytics' score of -2.00 indicating that Sangoma Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Sangoma Technologies	Positive
Cardlytics	Very Negative

Sangoma Technologies has a net margin of -3.04% compared to Cardlytics' net margin of -46.03%. Sangoma Technologies' return on equity of -2.26% beat Cardlytics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sangoma Technologies	-3.04%	-2.26%	-1.71%
Cardlytics	-46.03%	-956.56%	-34.57%

Sangoma Technologies has higher revenue and earnings than Cardlytics. Sangoma Technologies is trading at a lower price-to-earnings ratio than Cardlytics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sangoma Technologies	$236.69M	0.49	-$5.01M	-$0.19	N/A
Cardlytics	$233.27M	0.15	-$103.49M	-$1.77	N/A

Summary

Sangoma Technologies beats Cardlytics on 13 of the 16 factors compared between the two stocks.

How does Cardlytics compare to Cloopen Group?

Cardlytics (NASDAQ:CDLX) and Cloopen Group (NYSE:RAAS) are both computer software companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk.

68.1% of Cardlytics shares are held by institutional investors. 5.9% of Cardlytics shares are held by company insiders. Comparatively, 9.8% of Cloopen Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Cardlytics presently has a consensus price target of $1.00, indicating a potential upside of 67.11%. Given Cardlytics' stronger consensus rating and higher probable upside, analysts clearly believe Cardlytics is more favorable than Cloopen Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardlytics	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33
Cloopen Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Cardlytics had 1 more articles in the media than Cloopen Group. MarketBeat recorded 1 mentions for Cardlytics and 0 mentions for Cloopen Group. Cloopen Group's average media sentiment score of 0.00 beat Cardlytics' score of -2.00 indicating that Cloopen Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Cardlytics	Very Negative
Cloopen Group	Neutral

Cloopen Group has lower revenue, but higher earnings than Cardlytics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardlytics	$233.27M	0.15	-$103.49M	-$1.77	N/A
Cloopen Group	$76.61M	1.56	-$34.23M	N/A	N/A

Cloopen Group has a net margin of 0.00% compared to Cardlytics' net margin of -46.03%. Cloopen Group's return on equity of 0.00% beat Cardlytics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardlytics	-46.03%	-956.56%	-34.57%
Cloopen Group	N/A	N/A	N/A

Summary

Cloopen Group beats Cardlytics on 7 of the 12 factors compared between the two stocks.

Get Cardlytics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CDLX vs. The Competition

Export

Metric	Cardlytics	Technology Services Industry	Business Sector	NASDAQ Exchange
Market Cap	$35.43M	$4.22B	$6.70B	$12.46B
Dividend Yield	N/A	2.07%	3.02%	5.34%
P/E Ratio	-0.34	41.66	27.82	23.64
Price / Sales	0.15	47.18	407.57	112.57
Price / Cash	N/A	42.86	24.70	57.17
Price / Book	-4.99	4.84	5.86	6.37
Net Income	-$103.49M	$31.69M	$205.22M	$337.36M
7 Day Performance	-11.32%	-0.01%	0.01%	-3.07%
1 Month Performance	-28.64%	-3.75%	-0.32%	0.37%
1 Year Performance	-64.38%	27.52%	33.82%	27.87%

Cardlytics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CDLX Cardlytics	1.9668 of 5 stars	$0.60 -1.9%	$1.00 +67.1%	-65.3%	$35.43M	$233.27M	N/A	500	Negative News
CMCM Cheetah Mobile	0.5121 of 5 stars	$4.41 -4.5%	N/A	-5.1%	$140.06M	$1.15B	N/A	850	News Coverage
PODC PodcastOne	1.2203 of 5 stars	$4.76 -3.7%	N/A	+121.9%	$135.79M	$60.10M	N/A	N/A
ARBE Arbe Robotics	2.7518 of 5 stars	$1.19 +7.7%	$2.33 +96.9%	-38.5%	$134.91M	$1.03M	N/A	120
SANG Sangoma Technologies	2.1924 of 5 stars	$3.64 -2.1%	$4.00 +9.9%	-35.6%	$123.96M	$236.69M	N/A	730	News Coverage Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CDLX) was last updated on 6/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cardlytics (CDLX) Competitors

CDLX vs. CMCM, PODC, ARBE, SANG, and RAAS

How does Cardlytics compare to Cheetah Mobile?

Summary

How does Cardlytics compare to PodcastOne?

Summary

How does Cardlytics compare to Arbe Robotics?

Summary

How does Cardlytics compare to Sangoma Technologies?

Summary

How does Cardlytics compare to Cloopen Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CDLX vs. The Competition

Cardlytics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cardlytics (CDLX) Competitors

CDLX vs. CMCM, PODC, ARBE, SANG, and RAAS

How does Cardlytics compare to Cheetah Mobile?

Is CDLX or CMCM more profitable?

Which has more volatility & risk, CDLX or CMCM?

Do institutionals and insiders hold more shares of CDLX or CMCM?

Do analysts prefer CDLX or CMCM?

Which has better earnings and valuation, CDLX or CMCM?

Does the media refer more to CDLX or CMCM?

Summary

How does Cardlytics compare to PodcastOne?

Which has more risk and volatility, PODC or CDLX?

Do institutionals and insiders hold more shares of PODC or CDLX?

Which has higher earnings & valuation, PODC or CDLX?

Does the media favor PODC or CDLX?

Do analysts recommend PODC or CDLX?

Is PODC or CDLX more profitable?

Summary

How does Cardlytics compare to Arbe Robotics?

Is CDLX or ARBE more profitable?

Which has stronger valuation and earnings, CDLX or ARBE?

Which has more risk and volatility, CDLX or ARBE?

Do insiders and institutionals believe in CDLX or ARBE?

Do analysts rate CDLX or ARBE?

Does the media refer more to CDLX or ARBE?

Summary

How does Cardlytics compare to Sangoma Technologies?

Which has more risk & volatility, SANG or CDLX?

Do analysts rate SANG or CDLX?

Do institutionals and insiders have more ownership in SANG or CDLX?

Does the media favor SANG or CDLX?

Is SANG or CDLX more profitable?

Which has stronger earnings and valuation, SANG or CDLX?

Summary

How does Cardlytics compare to Cloopen Group?

Do institutionals & insiders believe in CDLX or RAAS?

Do analysts rate CDLX or RAAS?

Does the media favor CDLX or RAAS?

Which has preferable valuation and earnings, CDLX or RAAS?

Is CDLX or RAAS more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CDLX vs. The Competition

Cardlytics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools